Panbio登革熱病毒抗體檢測試劑盒
：
廣州健侖生物科技有限公司是一家專注的診斷試劑領域生產、銷售的廠商，與多家診斷公司進行強強聯手，本公司為澳大利亞PANBIO、美國CorteZ、美國BinaxNow、日本富士、日本生研等多家企業在中國地區的總代理商及負責售后服務工作。
*zui好的登革熱診斷產品，世界銷售遙遙的品牌.擁有FDA、CE歐盟認證及眾多
從發病率和死亡率與經濟成本來看，登革熱為zui嚴重的由蚊蟲傳播的病毒性疾病。該病毒主要是通過埃及伊蚊傳播，超過100個國家報告過登革熱爆發，有2.5億人生活在登革高感染區，每年會發生5000萬到1億例登革出血熱，200000-500000例登革感染者zui終發展為登革出血熱，平均有5%的登革出血熱患者會死亡。 | ||||||||||||||||||||||||||||||||||||||
| 三、Panbio®登革熱全線產品 | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| 三、Panbio®產品具體介紹 | ||||||||||||||||||||||||||||||||||||||
1、登革熱快速檢測試劑（Dengue Duo Cassette） | ||||||||||||||||||||||||||||||||||||||
| 用于定性的快速檢測人群血清、血漿或全血中登革病毒的IgM及IgG抗體。可在15分鐘內檢測結果。 | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| 2、登革IgM捕捉ELISA（Dengue IgM Capture） | ||||||||||||||||
用于定性的檢測人群血清中登革病毒的IgM抗體，用于臨床實驗室對具有持續發燒的登革熱癥狀的病人的輔助診斷。 | ||||||||||||||||
廣州健侖生物科技有限公司為Panbio品牌中國地區總代理，負責該產品的總經銷及售后服務工作. | ||||||||||||||||
| 4、登革早期ELISA（Dengue Early ELISA） | ||||||||||||||||
| 用于定性檢測血清中登革病毒的NS1抗原（血清型1、2、3及4型）。用于臨床實驗室對有持續發燒的登革熱癥狀病人的輔助性診斷。 | ||||||||||||||||
| ||||||||||||||||
5、登革IgG間接ELISA（Dengue IgG Indirect） | ||||||||||||||||
用于定性檢測血清中登革病毒（血清型1、2、3及4型）的IgG抗體，用于臨床實驗室對具有持續發燒的登革感染癥狀或接觸史的患者的輔助性診斷。 | ||||||||||||||||
| ||||||||||||||||
| 6、登革IgM & IgG聯檢ELISA（Dengue Duo IgM & IgG Capture） | ||||||||||||||||
用于定性檢測血清中登革病毒的IgM和IgG抗體。可以區分原發感染與繼發感染。 | ||||||||||||||||
| ||||||||||||||||
1、1988年成立，2001年澳大利亞證券交易所上市.
1）關于蟲媒感染性疾病及熱帶感染性疾病的專業供貨商
2）產品面向蟲媒感染性疾病的監測，在國內疾控系統具有*的認知和認可度
2、2010年銷售800萬檢測，為30多種疾病提供診斷
3、革新的歷史及面向市場需求提供回應；
1）登革熱：*個商用試劑盒，目前擁有zui先機，zui完善的產品線及售后服務系統
2）羅斯河熱：*個商用試劑盒
3）系尼羅河病毒：*個獲得FDA批準的試劑盒
新產品
恙蟲熱快速檢測試劑/檢測卡
日本腦膜炎-登革熱聯檢ELISA等
Panbio登革熱診斷試劑盒
PANBIO Introduction Diagnosis
Panbio empowers people to take control of their health by actively integrating diagnostics and health management solutions to provide timely, actionable information in a range of environments from hospital to home.
We provide in vitro diagnostics in the fields of cardiovascular, infectious diseases, women's health, prenatal care, drugs of abuse and oncology. We support healthcare workers and patients by developing simple diagnostic equipment to ensure better quality in both inpatient and outpatient care.
Through the strategic acquisition of a number of companies, we have steadily grown and have expanded our product and service offering. We are a market leader engaged in health care management programs and services and offer comprehensive support for health care professionals and patients across the globe.
We are a global leader in the field of rapid diagnostic tests which are designed to improve the quality of patient care. Specific product lines include tests for the rapid and early diagnosis of myocardial infarction, influenza, acute kidney damage, HIV infection, and for the exclusion of acute risk of premature labour and delivery. We also support the patients' ability to self-manage a number of common health issues, for example by offering an easy-to-use device to monitor blood coagulation. A device patients may use in the home.
By supplying products that are accurate, effective, consistent and reliable for use in both the home and clinical environments, Alere is enabling doctors and patients to better connect with each other and provide the information necessary to make better healthcare decisions.
China's general agent：
GuangZhou Jianlun Biology Technology Co.，Ltd
+86-/ ：+86- ：Service@jianlun.com
